DeepZyme · Learning Deep Representations of Enzymes for Predicting Catalytically-Beneficial Mutations
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2021-01-01 → 2022-12-31
- Финансиране от ЕС
- 162 806 €
- Участници
- 1
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Ензимите и техните мутации се анализират чрез дълбоко обучение, за да се предвидят промени, които подобряват каталитичната им активност. Това помага за създаването на нови ензими, които да ускорят синтеза на лекарствени молекули.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
DeepZyme: Learning Deep Representations of Enzymes for Predicting Catalytically-Beneficial Mutations
During the course of evolution nature has created and optimized extraordinary protein catalysts, named enzymes, that are fundamental in all reigns of life. Enzymes facilitate complex chemical reactions at physiological conditions, accelerating their rates by several orders of magnitude and being highly selective over alternative –undesired– chemical transformations. Understanding how enzymes work and how to engineer their functions is essential for many disciplines, with applications ranging from medical therapies to biotechnological devices. The main challenge towards the rational control of enzymes is that given their complexity, it is not trivial to predict modifications –known as mutations– that are beneficial for their activity. The DeepZyme project aims to develop a model for the prediction of such modifications, taking advantage of revolutionary techniques in the field of deep learning. We propose to obtain condensed “representations” of enzymes by leveraging their sequence, structure and catalytic information. These representations can be suitably designed to describe enzymatic information that is available in nature, and learn how enzymes have been tuned by selection pressures along evolution. Navigating in the space of enzyme representations will allow us to finely tune their properties, and thereby guide a rational design process. Our model will be used together with other state-of-the-art techniques (including molecular dynamics, Markov state models and quantum mechanics / molecular mechanics) to generate from scratch an enzyme able to catalyze chemical reactions along the synthesis of drug-like molecules.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
During the course of evolution nature has created and optimized extraordinary protein catalysts, named enzymes, that are fundamental in all reigns of life. Enzymes facilitate complex chemical reactions at physiological conditions, accelerating their rates by several orders of magnitude and being highly selective over alternative –undesired– chemical transformations. Understanding how enzymes work and how to engineer their functions is essential for many disciplines, with applications ranging from medical therapies to biotechnological devices. The main challenge towards the rational control of enzymes is that given their complexity, it is not trivial to predict modifications –known as mutations– that are beneficial for their activity. The DeepZyme project aims to develop a model for the prediction of such modifications, taking advantage of revolutionary techniques in the field of deep learning. We propose to obtain condensed “representations” of enzymes by leveraging their sequence, structure and catalytic information. These representations can be suitably designed to describe enzymatic information that is available in nature, and learn how enzymes have been tuned by selection pressures along evolution. Navigating in the space of enzyme representations will allow us to finely tune their properties, and thereby guide a rational design process. Our model will be used together with other state-of-the-art techniques (including molecular dynamics, Markov state models and quantum mechanics / molecular mechanics) to generate from scratch an enzyme able to catalyze chemical reactions along the synthesis of drug-like molecules.
Оригинален текст от CORDIS (на английски).
Участници
- FREIE UNIVERSITAET BERLIN · BerlinКоординаторГермания
Връзки
Данни: CORDIS, © Европейски съюз
